Charles River CEO Jim Foster Marks 50-Year Career

NYSE to feature Charles River Laboratories leader on NYSE Live for milestone anniversary

Apr. 6, 2026 at 12:55pm

Got story updates? Submit your updates here. ›

The New York Stock Exchange (NYSE) announced that James Foster, Chairman, President and CEO of Charles River Laboratories (CRL), will join NYSE Live to discuss his 50-year career transformation and leadership milestones at the company. The appearance is part of NYSE's partnership with the HumanX AI conference in San Francisco, where the exchange will provide market insights and interviews with industry leaders.

Why it matters

Foster's 50-year tenure at Charles River Laboratories represents a remarkable leadership legacy in the pharmaceutical and life sciences industry. His appearance on NYSE Live is expected to be of interest to investors as it highlights the long-term success and stability of CRL's management under his guidance.

The details

Charles River Laboratories is a major provider of products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the world accelerate their research and drug development efforts. Foster has served as Chairman, President and CEO of CRL since 1992, leading the company through significant growth and expansion over the past three decades.

  • James Foster will join NYSE Live on April 6, 2026 to discuss his 50-year career at Charles River Laboratories.
  • The NYSE is partnering with the HumanX AI conference in San Francisco, which is taking place this week.

The players

James Foster

Chairman, President and CEO of Charles River Laboratories (CRL), a leading provider of products and services to the pharmaceutical and biotechnology industries. Foster has served in this role since 1992 and is celebrating his 50-year career at the company.

New York Stock Exchange (NYSE)

The largest stock exchange in the world by market capitalization of its listed companies. The NYSE is partnering with the HumanX AI conference in San Francisco this week and will be providing market insights and interviews with industry leaders.

Charles River Laboratories (CRL)

A major provider of products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the world accelerate their research and drug development efforts.

Got photos? Submit your photos here. ›

What they’re saying

“NYSE is partnering with the HumanX AI conference and will have Ashley Mastronardi on site to report from the event. According to NYSE, the partnership aims to highlight AI innovation and feature interviews with industry leaders at Moscone Center.”

— NYSE

“James Foster of Charles River Laboratories (CRL) will join NYSE Live to discuss his transformation legacy and career milestones. According to NYSE, the appearance highlights CRL leadership and may be of investor interest given Foster's 50-year tenure.”

— NYSE

What’s next

Investors and industry analysts will be closely watching James Foster's appearance on NYSE Live on April 6th, as it provides an opportunity to hear directly from the long-serving CEO about Charles River Laboratories' strategic vision and growth plans.

The takeaway

James Foster's 50-year tenure as CEO of Charles River Laboratories represents an impressive leadership legacy in the highly competitive pharmaceutical and life sciences industry. His appearance on the NYSE platform underscores the company's stability and long-term success under his guidance, which is likely to be of keen interest to investors.